Opioids abated with 'injectrode' neuromodulation technique
An electrode that is injected into a patient as a liquid before curing inside the body could make neuromodulation therapies more reliable, less invasive and more economical.
This is the claim of University of Wisconsin-Madison biomedical engineers and their collaborators whose creation - dubbed the injectrode – is described in a paper published online in Advanced Healthcare Materials.
Neuromodulation therapies involve electrically stimulating nerves to reduce epileptic seizures, soothe chronic pain, and treat depression and a host of other health conditions without the use of conventional drugs like opioids.
Electrode implants elucidate whole-brain map of electrical connectivity
Under the skin: A new breed of biomedical implant
According to the team, current neuromodulation treatments rely on surgically implanted devices that can cost up to six figures, require complex procedures to install, and often fail as they are rigid devices attempting to mesh with soft biological tissue.
"Typical implants are really stiff, and so as the body moves, they wear and tear and break down,” said Kip Ludwig, a UW-Madison professor of biomedical engineering and neurological surgery.
Register now to continue reading
Thanks for visiting The Engineer. You’ve now reached your monthly limit of news stories. Register for free to unlock unlimited access to all of our news coverage, as well as premium content including opinion, in-depth features and special reports.
Benefits of registering
-
In-depth insights and coverage of key emerging trends
-
Unrestricted access to special reports throughout the year
-
Daily technology news delivered straight to your inbox
Experts speculate over cause of Iberian power outages
I´m sure politicians will be thumping tables and demanding answers - while Professor Bell, as reported above, says ´wait for detailed professional...